Ferring Pharmaceuticals announced today three abstracts featuring ADSTILADRIN® (nadofaragene firadenovec-vncg) will be presented at the 2025 American Society of Clinical Oncologists Genitourinary ...
I heard what she said but didn’t quite get it. Her observation didn’t sink in, and wouldn’t sink in until years later.” ...